Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort (original) (raw)
References
- American Academy of Neurology (1991). Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type1 (HIV-1) infection: report of a Woking Group of the American Accademy of Neurol AIDS task Force. Neurology 41: 778–785.
Google Scholar - Becker JT, Lopez OL, Dew MA, Aizenstein HJ (2004). Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS 18 (Suppl 1): S11S18.
Article Google Scholar - Brew BJ (2004). Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 18(Suppl 1): S75-S78.
Article CAS PubMed Google Scholar - D’Arminio Monforte A, Cinque P, Mocroft A, Goebel FD, Antunes F, Katlama C, Stenz Justesen U, Vella S, Kirk O, Lundgren J (2004). Changing incidence of central nervous system diseases in the EuroSIDA cohort. Ann Neurol 55: 320–328.
Article Google Scholar - Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ (1999). Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13: 1249–1253.
Article CAS PubMed Google Scholar - Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ (2003). Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 17: 1539–1545.
Article PubMed Google Scholar - Ferrando S, Van Gorp W, McElhiney M, Goggin K, Sewell M, Rabkin J (1998). Highly active antiretroviral treatment in HIV infection: benefits of neuropsychological function. AIDS 12: F65-F70.
Article CAS PubMed Google Scholar - Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, Wesnes KA, Taylor-Robinson SD (2002). Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 35: 433–439.
Article PubMed Google Scholar - Hilsabeck RC, Perry W, Hassanein TI (2002). Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 35: 440–446.
Article PubMed Google Scholar - Justice AC, McGinnis KA, Atkinson JH, Heaton RK, Young C, Sadek J, Madenwald T, Becker JT, Conigliaro J, Brown ST, Rimland D, Crystal S, Simberkoff M, Veterans Aging Cohort 5-Site Study Project Team (2004). Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study. AIDS 18(Suppl 1): S49-S59.
Article PubMed Google Scholar - Letendre S, Cherner M, Ellis R, Marcotte T, Heaton R, McCutchan JA, Grant I. Individuals coinfected with hepatitis C (HCV) and HIV are more cognitively impaired than those with either virus alone (2002). J NeuroVirol 8(Suppl 1): 27–28.
Google Scholar - Lezak MD (1983). Neuropsychological assessment. New York: Oxford University Press.
Google Scholar - Mack KA, Ory MG (2003). AIDS and older Americans at the end of the Twentieth Century. J Acquir Immune Defic Syndr 33(Suppl 2): S68-S75.
PubMed Google Scholar - Masliah E, De Teresa RM, Mallory RE, Hansen LA (2000). Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 14: 69–74.
Article CAS PubMed Google Scholar - Navia BA, Price RW (1987). The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol 44: 65–69.
CAS PubMed Google Scholar - Neuenburg JK, Brodt HR, Herndier BG, Bickel M, Bacchetti P, Price RW, Grant RM, Schlote W (2002). HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 31: 171–177.
PubMed Google Scholar - Ryan EL, Morgello S, Isaacs K, Naseer M, Gerits P, The Manhattan HIV Brain Bank (2004). Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology 62: 957–962.
CAS PubMed Google Scholar - Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC, Multicenter AIDS Cohort Study (2001). HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998. Neurology 56: 257–260.
CAS PubMed Google Scholar - Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. J NeuroVirol 8: 136–142.
Article PubMed Google Scholar - Sidtis JJ, Gatsonis C, Price RW, Singer EJ, Collier AC, Richman DD, Hirsch MS, Schaerf FW, Fischl MA, Kieburtz K, Simpson D, Koch A, Feinberg J, Dafni U, and the AIDS Clinical Trial Group (1993). Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group. Ann Neurol 33: 343–349.
Article CAS PubMed Google Scholar - Spinnler H, Tognoni G (1987). Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci 6(Suppl 8): 49–54.
Google Scholar - Tozzi V, Balestra P, Galgani S, Murri R, Bellagamba R, Narciso P, Antinori A, Giulianelli M, Tosi G, Costa M, Sampaolesi A, Fantoni M, Noto P, Ippolito G, Wu AW (2003). Neurocognitive performance and quality of life in patients with HIV infection. AIDS Res Hum Retrovirus 19: 643–652.
Article Google Scholar - Tozzi V, Balestra P, Galgani S, Narciso P, Sampaolesi A, Antinori A, Giulianelli M, Serraino D, Ippolito G (2001). Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years. JAIDS 28: 19–27.
CAS PubMed Google Scholar